Skip to main content
. 2019 Nov 4;6(12):2413–2425. doi: 10.1002/acn3.50932

Figure 1.

Figure 1

Kaplan–Meier graph showing the time from in‐MDZ application to the cessation of SE in patients rated as responders and nonresponders to in‐MDZ. In three cases rated as nonresponders, other anticonvulsants such as lorazepam, brivaracetam, or lacosamide were given prior to the end of SE.